BDX Becton Dickinson
NYSE · SEC CIK 10795 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $2.78M 21 sales by 5 insiders
- Filings on record
- 294 since 2021-08-04, latest 2026-09-03 19:24
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Polen Thomas E Jr | COB, CEO, Pres, Dir | — | $1.17M |
| Garrison Michael David | EVP, Pres Med.Essntl, BioPharm | — | $784.2K |
| Goette Roland | EVP, Pres, EMEA | — | $440.9K |
| SCOTT BERTRAM L | Dir | — | $212.3K |
| Feld Michael | EVP, Pres, Life Sciences | — | $167.4K |
| Menziuso Peter | EVP, Pres, BDI | — | — |
| Roque Vitor | Interim CFO | — | — |
| Spikner Pamela L. | SVPController, Chief Acct Off | — | — |
| Shan David | EVP, Chief ISC Off | — | — |
| Waldstreicher Joanne | Dir | — | — |
Transactions 334
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-30 | 2025-01-28 | BDX | Brown William M | Dir | A - Grant | $0.00 | +930 | 3,486 | +36% | $0 | |
| 2025-01-22 | 2025-01-21 | BDX | Neal Shana Carol | EVP, CHRO | S - Sale | $240.00 | -787 | 15.4K | -5% | -$188.9K | |
| 2025-01-22 | 2025-01-21 | BDX | Shan David | EVP, Chief ISC Off | S - Sale | $240.00 | -500 | 5,741 | -8% | -$120.0K | |
| 2025-01-21 | 2025-01-17 | BDX | Garrison Michael David | EVP, Pres, Medical | S - Sale | $236.51 | -597 | 5,544 | -10% | -$141.2K | |
| DM | 2025-01-10 | 2022-11-18+ | BDX | Neal Shana Carol | EVP, CHRO | F - Tax | $0.00 | -94 | 16.9K | -0.6% | $0 |
| DM | 2025-01-10 | 2022-11-18+ | BDX | Neal Shana Carol | EVP, CHRO | M - OptEx | $0.00 | +331 | 16.9K | +2% | $0 |
| D | 2025-01-10 | 2025-01-07 | BDX | Neal Shana Carol | EVP, CHRO | S - Sale+OE | $235.00 | -788 | 16.2K | -5% | -$185.2K |
| 2025-01-06 | 2025-01-03 | BDX | Shan David | EVP, Chief ISC Off | F - Tax | $0.00 | -44 | 6,241 | -0.7% | $0 | |
| 2024-12-20 | 2024-12-19 | BDX | Garrison Michael David | EVP, Pres, Medical | S - Sale | $223.33 | -2,838 | 6,141 | -32% | -$633.8K | |
| 2024-12-10 | 2024-12-06 | BDX | Neal Shana Carol | EVP, CHRO | S - Sale | $220.49 | -1,000 | 17.0K | -6% | -$220.5K | |
| DM | 2024-12-10 | 2024-12-06+ | BDX | Goette Roland | EVP, Pres, EMEA | S - Sale+OE | $220.76 | -5,121 | 24.3K | -17% | -$1.13M |
| D | 2024-12-10 | 2024-12-06 | BDX | Goette Roland | EVP, Pres, EMEA | D - Sale to Iss | $221.01 | -9,490 | 14.9K | -39% | -$2.10M |
| DM | 2024-12-10 | 2024-12-06 | BDX | Goette Roland | EVP, Pres, EMEA | M - OptEx | $157.30 | +13.3K | 22.5K | +146% | +$2.10M |
| 2024-12-06 | 2024-12-05 | BDX | Shan David | EVP, Chief ISC Off | S - Sale | $220.25 | -1,500 | 6,285 | -19% | -$330.4K | |
| A | 2024-12-03 | 2024-11-26 | BDX | Mocherla Pavan Kumar | EVP, Pres, Greater Asia | F - Tax | $0.00 | -25 | 2,847 | -0.9% | $0 |
| D | 2024-11-29 | 2024-11-26 | BDX | Garrison Michael David | EVP, Pres, Medical | F - Tax | $0.00 | -1,230 | 8,979 | -12% | $0 |
| DM | 2024-11-29 | 2024-11-26 | BDX | Garrison Michael David | EVP, Pres, Medical | A - Grant | $0.00 | +4,828 | 7,934 | +155% | $0 |
| D | 2024-11-29 | 2024-11-26 | BDX | Goette Roland | EVP, Pres, EMEA | F - Tax | $0.00 | -196 | 15.5K | -1% | $0 |
| DM | 2024-11-29 | 2024-11-26 | BDX | Goette Roland | EVP, Pres, EMEA | A - Grant | $0.00 | +3,105 | 15.7K | +25% | $0 |
| D | 2024-11-29 | 2024-11-26 | BDX | Shan David | EVP, Chief ISC Off | F - Tax | $0.00 | -124 | 7,785 | -2% | $0 |
| DM | 2024-11-29 | 2024-11-26 | BDX | Shan David | EVP, Chief ISC Off | A - Grant | $0.00 | +2,216 | 7,909 | +39% | $0 |
| DM | 2024-11-29 | 2024-11-26 | BDX | Byrd Richard | EVP, Pres Interventional | A - Grant | $0.00 | +4,495 | 10.6K | +74% | $0 |
| D | 2024-11-29 | 2024-11-26 | BDX | Byrd Richard | EVP, Pres Interventional | F - Tax | $0.00 | -1,204 | 9,351 | -11% | $0 |
| DM | 2024-11-29 | 2024-11-26 | BDX | Mocherla Pavan Kumar | EVP, Pres Greater Asia | A - Grant | $0.00 | +1,055 | 2,872 | +58% | $0 |
| D | 2024-11-29 | 2024-11-26 | BDX | Mocherla Pavan Kumar | EVP, Pres Greater Asia | F - Tax | $0.00 | -20 | 2,852 | -0.7% | $0 |
| D | 2024-11-29 | 2024-11-26 | BDX | DelOrefice Christopher | EVP, CFO | F - Tax | $0.00 | -5,192 | 21.5K | -19% | $0 |
| DM | 2024-11-29 | 2024-11-26 | BDX | DelOrefice Christopher | EVP, CFO | A - Grant | $0.00 | +13.9K | 17.7K | +368% | $0 |
| D | 2024-11-29 | 2024-11-26 | BDX | Neal Shana Carol | EVP, CHRO | A - Grant | $0.00 | +2,109 | 18.5K | +13% | $0 |
| D | 2024-11-29 | 2024-11-26 | BDX | Neal Shana Carol | EVP, CHRO | F - Tax | $0.00 | -509 | 18.0K | -3% | $0 |
| D | 2024-11-29 | 2024-11-26 | BDX | Feld Michael | EVP, Pres, Life Sciences | A - Grant | $0.00 | +2,553 | 9,190 | +38% | $0 |
| D | 2024-11-29 | 2024-11-26 | BDX | Polen Thomas E Jr | COB, CEO, Pres | F - Tax | $0.00 | -23.6K | 100.4K | -19% | $0 |
| DM | 2024-11-29 | 2024-11-26 | BDX | Polen Thomas E Jr | COB, CEO, Pres | A - Grant | $0.00 | +52.1K | 123.9K | +73% | $0 |
| D | 2024-11-29 | 2024-11-26 | BDX | Quinn Michelle | EVP, GC | F - Tax | $0.00 | -376 | 6,927 | -5% | $0 |
| DM | 2024-11-29 | 2024-11-26 | BDX | Quinn Michelle | EVP, GC | A - Grant | $0.00 | +2,348 | 7,303 | +47% | $0 |
| D | 2024-11-29 | 2024-11-26 | BDX | Ezell Antoine C | EVP, CMO, Pres Americas | F - Tax | $0.00 | -1,357 | 12.0K | -10% | $0 |
| DM | 2024-11-29 | 2024-11-26 | BDX | Ezell Antoine C | EVP, CMO, Pres Americas | A - Grant | $0.00 | +4,007 | 13.3K | +43% | $0 |
| 2024-09-09 | 2024-09-07 | BDX | DelOrefice Christopher | EVP, CFO | F - Tax | $0.00 | -466 | 12.8K | -4% | $0 | |
| 2024-09-04 | 2024-09-01 | BDX | DelOrefice Christopher | EVP, CFO | F - Tax | $0.00 | -254 | 13.3K | -2% | $0 | |
| 2024-09-04 | 2024-09-01 | BDX | Byrd Richard | EVP, Pres Interventional | F - Tax | $0.00 | -216 | 6,060 | -3% | $0 | |
| 2024-08-21 | 2024-08-20 | BDX | Feld Michael | EVP, Pres, Life Sciences | A - Grant | $0.00 | +6,637 | 6,637 | New | $0 | |
| D | 2024-08-15 | 2024-08-14 | BDX | Goette Roland | EVP, Pres EMEA | D - Sale to Iss | $234.08 | -4,018 | 12.6K | -24% | -$940.5K |
| D | 2024-08-15 | 2024-08-14 | BDX | Goette Roland | EVP, Pres EMEA | M - OptEx | $132.54 | +5,295 | 16.6K | +47% | +$701.8K |
| 2024-07-02 | 2024-07-01 | BDX | Spoerel Thomas J | SVPController, Chief Acct Off | F - Tax | $0.00 | -48 | 1,928 | -2% | $0 | |
| 2024-06-11 | 2024-06-10 | BDX | Spoerel Thomas J | SVP, Ctrl, Chief Acct Off | S - Sale | $239.31 | -300 | 1,976 | -13% | -$71.8K | |
| M | 2024-05-16 | 2024-05-15 | BDX | Goette Roland | EVP, Pres EMEA | S - Sale | $236.73 | -3,300 | 12.4K | -21% | -$781.2K |
| M | 2024-05-15 | 2024-05-13 | BDX | Goette Roland | EVP, Pres EMEA | S - Sale | $236.70 | -3,300 | 16.2K | -17% | -$781.1K |
| 2024-05-01 | 2024-04-30 | BDX | Garrison Michael David | EVP, Pres Medical | S - Sale | $232.81 | -1,715 | 5,381 | -24% | -$399.3K | |
| 2024-04-05 | 2024-04-04 | BDX | Neal Shana Carol | EVP, CHRO | F - Tax | $0.00 | -1,921 | 16.4K | -10% | $0 | |
| 2024-03-15 | 2024-03-14 | BDX | Spoerel Thomas J | SVP, Ctrl, Chief Acct Off | S - Sale | $238.29 | -282 | 2,276 | -11% | -$67.2K | |
| 2024-03-05 | 2024-03-01 | BDX | Ezell Antoine C | EVP, CMO, Pres NA | F - Tax | $0.00 | -282 | 9,320 | -3% | $0 | |
| 2024-03-05 | 2024-03-01 | BDX | Garrison Michael David | EVP, Pres Medical | F - Tax | $0.00 | -178 | 7,096 | -2% | $0 | |
| 2024-03-05 | 2024-03-01 | BDX | Spoerel Thomas J | SVP, Ctrl, Chief Acct Off | F - Tax | $0.00 | -36 | 2,558 | -1% | $0 | |
| 2024-01-25 | 2024-01-23 | BDX | Byington Carrie L | Dir | A - Grant | $0.00 | +900 | 2,855 | +46% | $0 | |
| 2024-01-25 | 2024-01-23 | BDX | RING TIMOTHY M | Dir | A - Grant | $0.00 | +900 | 56.9K | +2% | $0 | |
| 2024-01-25 | 2024-01-23 | BDX | Henderson Jeffrey William | Dir | A - Grant | $0.00 | +900 | 5,568 | +19% | $0 | |
| 2024-01-25 | 2024-01-23 | BDX | Brown William M | Dir | A - Grant | $0.00 | +900 | 2,512 | +56% | $0 | |
| 2024-01-25 | 2024-01-23 | BDX | BURZIK CATHERINE M | Dir | A - Grant | $0.00 | +900 | 13.2K | +7% | $0 | |
| 2024-01-25 | 2024-01-23 | BDX | SCOTT BERTRAM L | Dir | A - Grant | $0.00 | +900 | 35.2K | +3% | $0 | |
| 2024-01-25 | 2024-01-23 | BDX | Fraser Claire | Dir | A - Grant | $0.00 | +900 | 22.7K | +4% | $0 | |
| 2024-01-25 | 2024-01-23 | BDX | ECKERT R ANDREW | Dir | A - Grant | $0.00 | +900 | 8,124 | +12% | $0 | |
| 2024-01-25 | 2024-01-23 | BDX | Waldstreicher Joanne | Dir | A - Grant | $0.00 | +900 | 1,323 | +213% | $0 | |
| A | 2024-01-25 | 2019-01-22 | BDX | BURZIK CATHERINE M | Dir | A - Grant | $0.00 | +923 | 8,324 | +12% | $0 |
| 2024-01-25 | 2024-01-23 | BDX | Jones Christopher Ian Montague | Dir | A - Grant | $0.00 | +900 | 21.4K | +4% | $0 | |
| A | 2024-01-22 | 2023-11-16 | BDX | Goette Roland | EVP, Pres, EMEA | D - Sale to Iss | $235.07 | -2,233 | 14.9K | -13% | -$524.9K |
| 2024-01-04 | 2024-01-03 | BDX | Shan David | EVP, Chief ISC Off | F - Tax | $0.00 | -44 | 5,693 | -0.8% | $0 | |
| A | 2023-12-13 | 2023-01-24 | BDX | Jones Christopher Ian Montague | Dir | A - Grant | $0.00 | +848 | 20.2K | +4% | $0 |
| 2023-12-12 | 2023-12-11 | BDX | Garrison Michael David | EVP, Pres Medical | S - Sale | $232.46 | -1,239 | 7,274 | -15% | -$288.0K | |
| 2023-11-29 | 2023-11-28 | BDX | Byrd Richard | EVP, Pres Interventional | S - Sale | $238.47 | -2,156 | 4,120 | -34% | -$514.1K | |
| D | 2023-11-28 | 2023-11-26 | BDX | Hickey David | EVP, Pres, Life Sciences | A - Grant | $0.00 | +1,663 | 5,862 | +40% | $0 |
| DM | 2023-11-28 | 2023-11-26 | BDX | Garrison Michael David | EVP, Pres Medical | A - Grant | $0.00 | +5,002 | 10.2K | +97% | $0 |
| D | 2023-11-28 | 2023-11-26 | BDX | Garrison Michael David | EVP, Pres Medical | F - Tax | $0.00 | -1,646 | 8,513 | -16% | $0 |
| DM | 2023-11-28 | 2023-11-26 | BDX | Goette Roland | EVP, Pres EMEA | A - Grant | $0.00 | +3,190 | 18.6K | +21% | $0 |
| D | 2023-11-28 | 2023-11-26 | BDX | Goette Roland | EVP, Pres EMEA | F - Tax | $0.00 | -213 | 18.4K | -1% | $0 |
| DM | 2023-11-28 | 2023-11-26 | BDX | Mocherla Pavan Kumar | EVP, Pres Greater Asia | A - Grant | $0.00 | +751 | 1,881 | +66% | $0 |
| D | 2023-11-28 | 2023-11-26 | BDX | Mocherla Pavan Kumar | EVP, Pres Greater Asia | F - Tax | $0.00 | -64 | 1,817 | -3% | $0 |
| DM | 2023-11-28 | 2023-11-26 | BDX | Shan David | EVP, Chief ISC Off | A - Grant | $0.00 | +2,408 | 5,886 | +69% | $0 |
| D | 2023-11-28 | 2023-11-26 | BDX | Shan David | EVP, Chief ISC Off | F - Tax | $0.00 | -149 | 5,737 | -3% | $0 |
| D | 2023-11-28 | 2023-11-26 | BDX | Neal Shana Carol | EVP, CHRO | F - Tax | $0.00 | -258 | 18.3K | -1% | $0 |
| D | 2023-11-28 | 2023-11-26 | BDX | Neal Shana Carol | EVP, CHRO | A - Grant | $0.00 | +1,659 | 18.6K | +10% | $0 |
| DM | 2023-11-28 | 2023-11-26 | BDX | Spoerel Thomas J | SVPController, Chief Acct Off | A - Grant | $0.00 | +1,132 | 2,202 | +106% | $0 |
| D | 2023-11-28 | 2023-11-26 | BDX | Spoerel Thomas J | SVPController, Chief Acct Off | F - Tax | $0.00 | -365 | 2,594 | -12% | $0 |
| D | 2023-11-28 | 2023-11-26 | BDX | DelOrefice Christopher | EVP, CFO | A - Grant | $0.00 | +3,325 | 14.3K | +30% | $0 |
| D | 2023-11-28 | 2023-11-26 | BDX | DelOrefice Christopher | EVP, CFO | F - Tax | $0.00 | -812 | 13.5K | -6% | $0 |
| DM | 2023-11-28 | 2023-11-26 | BDX | Quinn Michelle | EVP, GC | A - Grant | $0.00 | +2,115 | 4,486 | +89% | $0 |
| D | 2023-11-28 | 2023-11-26 | BDX | Quinn Michelle | EVP, GC | F - Tax | $0.00 | -440 | 4,955 | -8% | $0 |
| DM | 2023-11-28 | 2022-11-26 | BDX | Polen Thomas E Jr | COB, CEO, Pres | A - Grant | $0.00 | +43.7K | 91.4K | +92% | $0 |
| D | 2023-11-28 | 2022-11-26 | BDX | Polen Thomas E Jr | COB, CEO, Pres | F - Tax | $0.00 | -19.6K | 71.8K | -21% | $0 |
| DM | 2023-11-28 | 2023-11-26 | BDX | Ezell Antoine C | EVP, CMO, Pres NA | A - Grant | $0.00 | +4,069 | 8,143 | +100% | $0 |
| D | 2023-11-28 | 2023-11-26 | BDX | Ezell Antoine C | EVP, CMO, Pres NA | F - Tax | $0.00 | -1,654 | 9,602 | -15% | $0 |
| DM | 2023-11-28 | 2023-11-26 | BDX | Byrd Richard | EVP, Pres Interventional | A - Grant | $0.00 | +4,341 | 7,785 | +126% | $0 |
| D | 2023-11-28 | 2023-11-26 | BDX | Byrd Richard | EVP, Pres Interventional | F - Tax | $0.00 | -1,509 | 6,276 | -19% | $0 |
| D | 2023-11-20 | 2023-11-16 | BDX | Goette Roland | EVP, Pres, EMEA | D - Sale to Iss | $235.07 | -1,751 | 15.4K | -10% | -$411.6K |
| D | 2023-11-20 | 2023-11-16 | BDX | Goette Roland | EVP, Pres, EMEA | M - OptEx | $107.12 | +3,544 | 17.2K | +26% | +$379.6K |
| 2023-09-08 | 2023-09-07 | BDX | DelOrefice Christopher | EVP, CFO | F - Tax | $0.00 | -601 | 11.0K | -5% | $0 | |
| 2023-09-06 | 2023-09-05 | BDX | Byrd Richard | EVP, Pres Interventional | S - Sale | $274.48 | -459 | 3,444 | -12% | -$126.0K | |
| 2023-09-05 | 2023-09-01 | BDX | DelOrefice Christopher | EVP, CFO | F - Tax | $0.00 | -353 | 11.6K | -3% | $0 | |
| 2023-09-05 | 2023-09-01 | BDX | Byrd Richard | EVP, Pres Interventional | F - Tax | $0.00 | -216 | 3,903 | -5% | $0 | |
| 2023-08-30 | 2023-08-28 | BDX | Fraser Claire | Dir | S - Sale | $281.66 | -848 | 21.6K | -4% | -$238.8K | |
| D | 2023-08-14 | 2023-08-11 | BDX | Hickey David | EVP, Pres, Life Sciences | D - Sale to Iss | $277.85 | -1,857 | 7,173 | -21% | -$516.0K |
| D | 2023-08-14 | 2023-08-11 | BDX | Hickey David | EVP, Pres, Life Sciences | M - OptEx | $132.54 | +3,883 | 9,030 | +75% | +$514.7K |
Purchase Sale Sale after option exercise All abbreviations